
FEATURED IN
How It Fits the Atlas System
IGG-1 — Foundation Layer
Immune support and gut integrity formulation
| Active Ingredient | Typical Dose Range | Primary Outcome Area | Indicative Effect Size | Timeframe | Evidence Type |
|---|---|---|---|---|---|
| High-IgG Bovine Colostrum (~60% IgG) | 10–20 g/day | URTI incidence ↓, gut permeability ↓ | ~30–60% ↓ URTI / ~40–50% ↓ permeability | Weeks–months | Human |
| Immunoglobulin G (IgG) | Intrinsic to colostrum | Immune recognition, pathogen binding | Significant ↑ | Ongoing | Human |
| Growth Factors (naturally occurring) | Intrinsic to colostrum | Gut epithelial integrity support | Supportive ↑ | Ongoing | Human / Preclinical |
| Manuka Honey (550 MGO) | 5–20 g/day | Antibacterial activity, gut environment support | ~5–10× antibacterial activity ↑ | - | In-vitro / Human-context |


